Journal article
Maintained anxiolytic effects of cannabidiol after treatment discontinuation in healthcare workers during the COVID-19 pandemic
Abstract
Objective: To assess whether the effects of oral administration of 300 mg of Cannabidiol (CBD) for 28 days on mental health are maintained for a period after the medication discontinuation. Methods: This is a 3-month follow-up observational and clinical trial study. The data were obtained from two studies performed simultaneously by the same team in the same period and region with Brazilian frontline healthcare workers during the COVID-19 …
Authors
Souza JDS; Zuardi AW; Guimarães FS; de Lima Osório F; Loureiro SR; Campos AC; Hallak JEC; Dos Santos RG; Silveira ILM; Pereira-Lima K
Journal
Frontiers in Pharmacology, Vol. 13, ,
Publisher
Frontiers
DOI
10.3389/fphar.2022.856846
ISSN
1663-9812